Key Points
- Rocket Lab announces Q1 2026 financial results after market close May 7
- Options market implies a 13.88% move in RKLB stock post-earnings
- Analyst consensus points to revenue around $190.9 million, representing 50%+ annual growth
- Per-share loss projected between $0.04–$0.07, better than prior year’s -$0.12
- Analyst price targets cluster between $83.31–$89.00 with “Moderate Buy” consensus
Rocket Lab will unveil Q1 2026 financial results after trading ends Thursday, May 7, scheduled for 5:00 PM ET. RKLB stock currently hovers around $77 per share, establishing a market capitalization near $43.9 billion.
Derivatives traders have positioned for a 13.88% directional movement following the announcement. This substantially exceeds Rocket Lab’s typical 4.65% post-earnings volatility observed across the previous four reporting periods.
Analyst forecasts call for quarterly revenue approaching $190.99 million, marking year-over-year growth exceeding 50%. Loss per share is projected to land between $0.04 and $0.07, showing advancement from the $0.12 deficit recorded during Q1 2025.
Beyond the published metrics, market participants are particularly focused on developments surrounding the Neutron rocket initiative.
Neutron represents a 43-meter partially reusable launch vehicle engineered for satellite deployment and cargo transport missions. The maiden flight is scheduled for late 2026 or early 2027. Strong execution on Neutron could position Rocket Lab as a viable competitor to SpaceX’s Falcon 9 platform.
Profitability Metrics and Contract Pipeline
Profitability indicators will receive significant attention. Rocket Lab’s GAAP gross margin registered 34.4% throughout 2025, requiring continued enhancement to achieve sustained profitability.
The firm concluded Q4 2025 carrying a record contract backlog valued at $1.85 billion. Shareholders will seek evidence demonstrating this pipeline is translating into actual revenue generation.
Executive Transactions and Fund Manager Moves
Regarding insider transactions, CEO Peter Beck divested 18,857 shares on March 2 at $69.59 each. CFO Adam Spice similarly offloaded 62,744 shares on the identical date, totaling approximately $4.37 million.
Combined insider sales reached $16.49 million across the preceding 90-day window. Company executives currently maintain 8.40% ownership.
Institutional capital has demonstrated contrasting behavior. Alliancebernstein expanded its holdings by 818.8% during Q3. Amundi elevated its position by 308.4% throughout the identical quarter.
State Street, Deutsche Bank, and Renaissance Technologies have similarly augmented their allocations. Institutional ownership now represents 71.78% of outstanding RKLB shares.
Regarding analyst coverage, Needham reduced its price objective from $110 to $95 while maintaining a Buy recommendation. Wells Fargo launched coverage with an Equal Weight stance and $60 target. Roth MKM lifted its forecast from $90 to $100 alongside a Buy rating.
Cantor Fitzgerald maintained an Overweight designation with an $85 price objective. The consensus analyst target stands at $83.31, spanning a range from approximately $60 to $100.
RKLB holds a “Moderate Buy” consensus rating from 17 Wall Street analysts — comprising two Strong Buys, nine Buys, five Holds, and one Sell.
The equity has fluctuated between $20.23 and $99.58 throughout the trailing twelve months. Technical indicators show the 50-day moving average positioned at $72.14 while the 200-day average rests at $68.10.
